Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Genprex, Inc.

NASDAQ: GNPX · Life Sciences · 5 alerts · CIK 1595248

Share price
$1.90Close, Nov 16
Market cap
$2.54M
Shares outstanding
1.33MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Genprex, Inc. filings on SEC EDGAR ↗

7:02 AM ET 8-K
Business Update

Genprex Business Update

Genprex announced that research from its sponsored collaboration with Meharry Medical College will be presented at the Gerontological Society of America 2026 Annual Scientific Meeting. The research explores the role of the TUSC2 gene, used in the company's lead candidate REQORSA, in cellular resilience and molecular processes associated with aging. This data may inform potential future therapeutic applications for REQORSA beyond its current focus on oncology and diabetes.

Counterparty
Meharry Medical College

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.